Current Volume 13(1) 2008 Supl. (48) - Page: 1

01 Jan 2008   

Comparing graft function for tacrolimus- and cyclosporine-treated patients. A long-term comparative study involving nephrotoxicity markers

Z. Marchewka, J. Kuźniar, K. Falkiewicz, B. Szymańska, M. Zynek-Litwin, D. Patrzałek, A. Długosz, M. Klinger

01 Jan 2008   

Drug lymphocyte level: New perspective in clinical immunosuppression monitoring

A. Barbari

01 Jan 2008   

Biomarkers assays for T-lymphocyte activation and proliferation applied in a multicenter clinical trial of AEB071 in renal transplantation

J. M. Kovarik, K. Budde, J. Steiger, J. M. Grinyo, F. Straube, A. Groenewegen, A. Vitalit, J. Geissler, J. Klupp, M. J. Barten

01 Jan 2008   

Inosine monophosphate dehydrogenase (IMPDH) activity after mycophenolate mofetil (MMF) in renal transplant patients receiving different immunosuppressive combined therapy and stable after at least 3 months’ administration

L. R. Chiarelli, M. Molinaro, C. Libetta, C. Tinelli, L. Cosmai, G. Valentini, A. Dal Canton, M. Regazzi

01 Jan 2008   

IMPDH activity on day 6 after kidney transplantation is significantly related to the risk of acute rejection in MMF treated patients

F. Sombogaard, R.A.A. Mathot, P. Glander, W. Weimar, T. van Gelder

01 Jan 2008   

Association between pharmacodynamic parameters and clinical events under therapy with EC-MPS in the early phase after kidney transplantation (KTx)

E. Wieland, M. Shipkova, Y. Martius, G. Hasche, C. Klett, R. Bolley, C. Olbricht

01 Jan 2008   

Tacrolimus – biotechnological prospects for a generic product

W. Gajzlerska, J. Turło, B. Gutkowska, F. Herold

01 Jan 2008   

Pharmacokinetics of mycophenolic acid and its phenyl-glucuronide in kidney transplant recipients with renal insufficiency

M. Chrzanowska, J. Kamińska, M. Głyda, N. Wachowiak

01 Jan 2008   

Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?

H. Tesfaye, R. Prusa, B. Jedlickova, J. Segethova

01 Jan 2008   

Therapeutic Drug Monitoring of tacrolimus in renal transplant patients

B. Solnica, K. Słowińska-Solnica, E. Ignacak, J. W. Naskalski

01 Jan 2008   

Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dose adaptation tool

J.E. Wallin, L. E. Friberg, A. Fasth, C. E. Staatz

01 Jan 2008   

Conversion from tacrolimus twice a day formulation to once-daily tacrolimus in kidney transplant recipients

D. Kamińska, M. Kuriata-Kordek, M. Boratyńska, K. Falkiewicz, M. Klinger

01 Jan 2008   

Evaluating co-medication and matrix interference influence on ion yields: A key step in therapeutic drug monitoring HPLC-MS/MS assay validation

C. Seger, M. Bock, K. Tentschert, A. Griesmacher

01 Jan 2008   

Comparison of tacrolimus levels obtained with twice-daily administration formulation (Prograf®) and with once-daily formulation (Advagraf®)

M. T. Rabuñal Álvarez, E. Fernández Gabriel, M. Outeda Macías, I. Martín Herranz

01 Jan 2008   

Evaluation of the Architect and Dimension tacrolimus and cyclosporine assays

P. Wallemacq, J. S. Goffinet, H. Ait-Youcef

01 Jan 2008   

Siemens Healthcare Diagnostics immunosuppressive drug monitoring solutions

T. Wei, N. Morjana, S. Goss, L. Bantum, Y. Yue, R. Janzen, G. Siefring

01 Jan 2008   

Evaluation of a commercially available whole blood calibrator and control kit for the analysis of cyclosporin A, everolimus, sirolimus and tacrolimus using LC/MS/MS technology

A. M. Taylor, T. N. Gamble, D. Blake, T. Drury, M. Ehrdhard

01 Jan 2008   

High throughput LC-MS/MS method for quantitative analysis of immunosuppressant drugs in whole blood using a triple quadrupole LC-MS/MS with an APCI source and implemented on column multiplexing LC system

R. Ruzicka, M. Kozak, V. Bodepudi, R. Loor, J. Zonderman

01 Jan 2008   

Sirolimus measurement by LC-MS/MS without solid phase extraction – overcoming the obstacles

N. W. Brown, P. Arampatzis, C. E. Gonde, M. Pires, J. Tracey, M. Tredger

29 Sep 2008   

The role of genetics and pharmacogenetic monitoring in transplantation

M. Masri

01 Jan 2008   

The CYP3A5*1/*3 single nucleotide polymorphism (SNP) determines the extent of drug interaction between tacrolimus and fluconazole in renal transplant recipients

H. de Jonge, M. Naesens, Y. Vanrenterghem, D. R. Kuypers

01 Jan 2008   

In vitro investigation of MRP 2 in the cyclosporine A – pravastatin interplay

R.l Kato, M. Nishide, C. Kodzu, Y. Ijiri, K. Tanaka

01 Jan 2008   

In vivo hepatic CYP3A4 activity is significantly higher in tacrolimus treated vs cyclosporine treated renal transplant recipients

H. de Jonge, M. Naesens, K. Verbeke, Y. Vanrenterghem, D. R. Kuypers

01 Jan 2008   

The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in caucasian liver transplant patients

A. Provenzani, M. Notarbartolo, F. Biondi, M. Labbozzetta, P. Poma, G. Vizzini, U. Palazzo, P. Polidori, F. Triolo, B. Gridelli, N. D'Alessandro

01 Jan 2008   

The pregnane X receptor C-25385t single nucleotide polymorphism (SNP) does not affect tacrolimus pharmacokinetics in a large cohort of renal transplant recipients

H. de Jonge, M. Naesens, Y. Vanrenterghem, D. R. Kuypers

01 Jan 2008 :   

Comparing graft function for tacrolimus- and cyclosporine-treated patients. A long-term comparative study involving nephrotoxicity markers

Z. Marchewka, J. Kuźniar, K. Falkiewicz, B. Szymańska, M. Zynek-Litwin, D. Patrzałek, A. Długosz, M. Klinger

Ann Transplant 2008; 13(1): 43-43 :: ID: 880211

599 0

01 Jan 2008 :   

Drug lymphocyte level: New perspective in clinical immunosuppression monitoring

A. Barbari

Ann Transplant 2008; 13(1): 43-43 :: ID: 880210

547 0

01 Jan 2008 :   

Biomarkers assays for T-lymphocyte activation and proliferation applied in a multicenter clinical trial of AEB071 in renal transplantation

J. M. Kovarik, K. Budde, J. Steiger, J. M. Grinyo, F. Straube, A. Groenewegen, A. Vitalit, J. Geissler, J. Klupp, M. J. Barten

Ann Transplant 2008; 13(1): 42-42 :: ID: 880209

562 0

01 Jan 2008 :   

Inosine monophosphate dehydrogenase (IMPDH) activity after mycophenolate mofetil (MMF) in renal transplant patients receiving different immunosuppressive combined therapy and stable after at least 3 months’ administration

L. R. Chiarelli, M. Molinaro, C. Libetta, C. Tinelli, L. Cosmai, G. Valentini, A. Dal Canton, M. Regazzi

Ann Transplant 2008; 13(1): 42-42 :: ID: 880208

579 0

01 Jan 2008 :   

IMPDH activity on day 6 after kidney transplantation is significantly related to the risk of acute rejection in MMF treated patients

F. Sombogaard, R.A.A. Mathot, P. Glander, W. Weimar, T. van Gelder

Ann Transplant 2008; 13(1): 41-42 :: ID: 880207

576 0

01 Jan 2008 :   

Association between pharmacodynamic parameters and clinical events under therapy with EC-MPS in the early phase after kidney transplantation (KTx)

E. Wieland, M. Shipkova, Y. Martius, G. Hasche, C. Klett, R. Bolley, C. Olbricht

Ann Transplant 2008; 13(1): 41-41 :: ID: 880206

551 0

01 Jan 2008 :   

Tacrolimus – biotechnological prospects for a generic product

W. Gajzlerska, J. Turło, B. Gutkowska, F. Herold

Ann Transplant 2008; 13(1): 40-41 :: ID: 880205

509 0

01 Jan 2008 :   

Pharmacokinetics of mycophenolic acid and its phenyl-glucuronide in kidney transplant recipients with renal insufficiency

M. Chrzanowska, J. Kamińska, M. Głyda, N. Wachowiak

Ann Transplant 2008; 13(1): 40-40 :: ID: 880204

512 0

01 Jan 2008 :   

Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?

H. Tesfaye, R. Prusa, B. Jedlickova, J. Segethova

Ann Transplant 2008; 13(1): 40-40 :: ID: 880203

531 0

01 Jan 2008 :   

Therapeutic Drug Monitoring of tacrolimus in renal transplant patients

B. Solnica, K. Słowińska-Solnica, E. Ignacak, J. W. Naskalski

Ann Transplant 2008; 13(1): 39-40 :: ID: 880202

524 0

01 Jan 2008 :   

Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dose adaptation tool

J.E. Wallin, L. E. Friberg, A. Fasth, C. E. Staatz

Ann Transplant 2008; 13(1): 39-39 :: ID: 880201

551 0

01 Jan 2008 :   

Conversion from tacrolimus twice a day formulation to once-daily tacrolimus in kidney transplant recipients

D. Kamińska, M. Kuriata-Kordek, M. Boratyńska, K. Falkiewicz, M. Klinger

Ann Transplant 2008; 13(1): 38-39 :: ID: 880200

670 0

01 Jan 2008 :   

Evaluating co-medication and matrix interference influence on ion yields: A key step in therapeutic drug monitoring HPLC-MS/MS assay validation

C. Seger, M. Bock, K. Tentschert, A. Griesmacher

Ann Transplant 2008; 13(1): 38-38 :: ID: 880198

502 0

01 Jan 2008 :   

Comparison of tacrolimus levels obtained with twice-daily administration formulation (Prograf®) and with once-daily formulation (Advagraf®)

M. T. Rabuñal Álvarez, E. Fernández Gabriel, M. Outeda Macías, I. Martín Herranz

Ann Transplant 2008; 13(1): 38-38 :: ID: 880199

513 0

01 Jan 2008 :   

Evaluation of the Architect and Dimension tacrolimus and cyclosporine assays

P. Wallemacq, J. S. Goffinet, H. Ait-Youcef

Ann Transplant 2008; 13(1): 37-38 :: ID: 880197

561 0

01 Jan 2008 :   

Siemens Healthcare Diagnostics immunosuppressive drug monitoring solutions

T. Wei, N. Morjana, S. Goss, L. Bantum, Y. Yue, R. Janzen, G. Siefring

Ann Transplant 2008; 13(1): 37-37 :: ID: 880196

561 0

01 Jan 2008 :   

Evaluation of a commercially available whole blood calibrator and control kit for the analysis of cyclosporin A, everolimus, sirolimus and tacrolimus using LC/MS/MS technology

A. M. Taylor, T. N. Gamble, D. Blake, T. Drury, M. Ehrdhard

Ann Transplant 2008; 13(1): 36-37 :: ID: 880195

577 0

01 Jan 2008 :   

High throughput LC-MS/MS method for quantitative analysis of immunosuppressant drugs in whole blood using a triple quadrupole LC-MS/MS with an APCI source and implemented on column multiplexing LC system

R. Ruzicka, M. Kozak, V. Bodepudi, R. Loor, J. Zonderman

Ann Transplant 2008; 13(1): 36-36 :: ID: 880194

561 0

01 Jan 2008 :   

Sirolimus measurement by LC-MS/MS without solid phase extraction – overcoming the obstacles

N. W. Brown, P. Arampatzis, C. E. Gonde, M. Pires, J. Tracey, M. Tredger

Ann Transplant 2008; 13(1): 36-36 :: ID: 880193

605 0

29 Sep 2008 :   

The role of genetics and pharmacogenetic monitoring in transplantation

M. Masri

Ann Transplant 2008; 13(1): 35-35 :: ID: 880192

562 0

01 Jan 2008 :   

The CYP3A5*1/*3 single nucleotide polymorphism (SNP) determines the extent of drug interaction between tacrolimus and fluconazole in renal transplant recipients

H. de Jonge, M. Naesens, Y. Vanrenterghem, D. R. Kuypers

Ann Transplant 2008; 13(1): 34-35 :: ID: 880191

568 0

01 Jan 2008 :   

In vitro investigation of MRP 2 in the cyclosporine A – pravastatin interplay

R.l Kato, M. Nishide, C. Kodzu, Y. Ijiri, K. Tanaka

Ann Transplant 2008; 13(1): 34-34 :: ID: 880190

589 0

01 Jan 2008 :   

In vivo hepatic CYP3A4 activity is significantly higher in tacrolimus treated vs cyclosporine treated renal transplant recipients

H. de Jonge, M. Naesens, K. Verbeke, Y. Vanrenterghem, D. R. Kuypers

Ann Transplant 2008; 13(1): 34-34 :: ID: 880189

580 0

01 Jan 2008 :   

The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in caucasian liver transplant patients

A. Provenzani, M. Notarbartolo, F. Biondi, M. Labbozzetta, P. Poma, G. Vizzini, U. Palazzo, P. Polidori, F. Triolo, B. Gridelli, N. D'Alessandro

Ann Transplant 2008; 13(1): 33-33 :: ID: 880188

520 0

01 Jan 2008 :   

The pregnane X receptor C-25385t single nucleotide polymorphism (SNP) does not affect tacrolimus pharmacokinetics in a large cohort of renal transplant recipients

H. de Jonge, M. Naesens, Y. Vanrenterghem, D. R. Kuypers

Ann Transplant 2008; 13(1): 33-33 :: ID: 880187

666 0

01 Jan 2008 :   

Modified release formulation in immunotherapy – the tacrolimus case

N. Undre

Ann Transplant 2008; 13(1): 32-32 :: ID: 880186

538 0

01 Jan 2008 :   

Generic substitution of immunosuppressive drugs – requirements for an equivalent product

A. Johnston, D. W. Holt

Ann Transplant 2008; 13(1): 31-31 :: ID: 880185

505 0

01 Jan 2008 :   

Generic products – requirements for drug registration

P. K. Kunicki

Ann Transplant 2008; 13(1): 30-30 :: ID: 880184

445 0

01 Jan 2008 :   

Therapeutic drug monitoring of immunosuppressive drugs – future perspectives

P. Wallemacq

Ann Transplant 2008; 13(1): 29-29 :: ID: 880183

465 0

01 Jan 2008 :   

Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring

D. R. Kuypers

Ann Transplant 2008; 13(1): 28-28 :: ID: 880182

491 0

01 Jan 2008 :   

Pharmacokinetics of mycophenolic acid: A comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients

T. van Gelde

Ann Transplant 2008; 13(1): 27-27 :: ID: 880181

549 0

01 Jan 2008 :   

Therapeutic drug monitoring of sirolimus and everolimus

E.M. Billaud

Ann Transplant 2008; 13(1): 26-26 :: ID: 880180

497 0

01 Jan 2008 :   

Therapeutic drug monitoring of tacrolimus

P. Wallemacq

Ann Transplant 2008; 13(1): 25-25 :: ID: 880179

511 0

01 Jan 2008 :   

Therapeutic drug monitoring of ciclosporin

A. Johnston, D. W. Holt

Ann Transplant 2008; 13(1): 24-24 :: ID: 880178

523 0

01 Jan 2008 :   

Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the curve in patients receiving concomitant sirolimus or cyclosporine

L. M. Shaw, M. Figurski, M. D. Pescovitz

Ann Transplant 2008; 13(1): 23-23 :: ID: 880177

459 0

01 Jan 2008 :   

Clinical application of population pharmacokinetic methods developed for immunosuppressive drugs

P. Marquet

Ann Transplant 2008; 13(1): 22-22 :: ID: 880176

553 0

01 Jan 2008 :   

What can we learn from proficiency testing of immunosuppressive drug assays?

D. W. Holt, A. Johnston

Ann Transplant 2008; 13(1): 21-21 :: ID: 880175

464 0

01 Jan 2008 :   

Immunoassays for immunosuppressive drugs – benefi ts and risks

W. Steimer

Ann Transplant 2008; 13(1): 20-20 :: ID: 880174

575 0

01 Jan 2008 :   

Review of the newest HPLC-MS/MS methods for determination of immunosuppressive drugs in clinical practice

M. Korecka

Ann Transplant 2008; 13(1): 19-19 :: ID: 880173

472 0

01 Jan 2008 :   

Introduction to high-performance liquid chromatography-tandem mass spectrometry: The gold standard for monitoring immunosuppressive drugs

P. J. Taylor

Ann Transplant 2008; 13(1): 18-18 :: ID: 880172

876 0

01 Jan 2008 :   

Biomarkers - as an adjunct to immunosuppressive drug monitoring

M. Oellerich

Ann Transplant 2008; 13(1): 17-17 :: ID: 880171

548 0

01 Jan 2008 :   

PK/PD modelling of immunosuppressive agents

E. Wyska

Ann Transplant 2008; 13(1): 16-16 :: ID: 880170

618 0

01 Jan 2008 :   

Drug transporters for immunosuppressive agents

I.A.M. MacPhee

Ann Transplant 2008; 13(1): 15-15 :: ID: 880169

408 0

01 Jan 2008 :   

Pharmacogenetics in immunotherapy: present knowledge and future perspectives

D. A. Hesselink

Ann Transplant 2008; 13(1): 13-14 :: ID: 880168

633 0

01 Jan 2008 :   

Pharmacokinetic principles of immunosuppressive-drugs

K. Budde, P. Glander

Ann Transplant 2008; 13(1): 12-12 :: ID: 880167

645 0

01 Jan 2008 :   

Clinical immunosuppression – current status

M. Klinger

Ann Transplant 2008; 13(1): 11-11 :: ID: 880166

610 0

01 Jan 2008 :   

New insight of immunosuppressive drugs related nephrotoxicity

E. Thervet

Ann Transplant 2008; 13(1): 10-10 :: ID: 880165

625 0

01 Jan 2008 :   

Organ transplantation in Poland

M. Durlik

Ann Transplant 2008; 13(1): 9-9 :: ID: 880164

681 0